These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17108216)

  • 1. Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
    Kamat AA; Sood AK; Dang D; Gershenson DM; Simpson JL; Bischoff FZ
    Ann N Y Acad Sci; 2006 Sep; 1075():230-4. PubMed ID: 17108216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated level of cell-free plasma DNA is associated with breast cancer.
    Zhong XY; Ladewig A; Schmid S; Wight E; Hahn S; Holzgreve W
    Arch Gynecol Obstet; 2007 Oct; 276(4):327-31. PubMed ID: 17431649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
    Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
    Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.
    Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R
    Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free circulating DNA as possible tumour marker in colorectal cancer.
    Boni L; Cassinotti E; Canziani M; Dionigi G; Rovera F; Dionigi R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S29-31. PubMed ID: 18024018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer.
    Capizzi E; Gabusi E; Grigioni AD; De Iaco P; Rosati M; Zamagni C; Fiorentino M
    Diagn Mol Pathol; 2008 Mar; 17(1):34-8. PubMed ID: 18303408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
    Gerovassili A; Garner C; Nicolaides KH; Thein SL; Rees DC
    Prenat Diagn; 2007 Feb; 27(2):104-10. PubMed ID: 17152117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
    Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
    Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell-free DNA levels in children on peritoneal dialysis.
    Ozkaya O; Bek K; Bedir A; Açikgöz Y; Ozdemir T
    Nephron Clin Pract; 2009; 113(4):c258-61. PubMed ID: 19684410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
    Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
    Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
    J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.
    Tomita H; Ichikawa D; Ikoma D; Sai S; Tani N; Ikoma H; Fujiwara H; Kikuchi S; Okamoto K; Ochiai T; Otsuji E
    Anticancer Res; 2007; 27(4C):2737-41. PubMed ID: 17695440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
    Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
    Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
    Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
    Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer.
    No JH; Kim K; Park KH; Kim YB
    Anticancer Res; 2012 Aug; 32(8):3467-71. PubMed ID: 22843932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of plasma cell-free DNA in patients with gastric cancer.
    Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
    Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker.
    Kamat AA; Baldwin M; Urbauer D; Dang D; Han LY; Godwin A; Karlan BY; Simpson JL; Gershenson DM; Coleman RL; Bischoff FZ; Sood AK
    Cancer; 2010 Apr; 116(8):1918-25. PubMed ID: 20166213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S; Senthil K; Nalini N
    Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.